#Epclusa

With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?

After inmates filed a class action lawsuit, Nevada agreed to treat all prisoners living with hepatitis C.

Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.

These recommendations are based on the World Health Organization’s guidelines.

Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

Gilead Sciences’ direct-acting antiviral regimen was previously approved for adults.

Six weeks, compared with the standard 12 weeks, was associated with an unacceptably high rate of viral relapse.

A recent study found that providing opioid use disorder treatment was associated with a high hep C cure rate and less drug use.

There are a variety of hepatitis C treatments offered for all genotypes, with various stages of liver damage.

Treatment for hep C has improved greatly over the past decades, with medications that treat more than one virus strain at the same time.

The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.

The drug can quickly reverse opioid-driven overdoses.

Past research has found that proton pump inhibitors and histamine H2 agonists are associated with lower levels of certain hep C drugs.

A quick overview of our reporting on the 53rd International Liver Congress in Vienna

These drugs are approved to treat all six major genotypes of hepatitis C.